Multiplex Assays Market Research 2023-2030: Increasing Focus on Personalized Medicine Boosting Utilization, Integration of AI and ML into Multiplex Assay Systems - ResearchAndMarkets.com

The "Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell), Technology (Flow Cytometry, PCR, Immunoassay), Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases)), Product, End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The global multiplex assays market is presently observing a significant uprising, with expectations to attain a market size of $6.24 billion by the year 2030. This growth trajectory corresponds to a Compound Annual Growth Rate (CAGR) of 9.0%, spanning from 2023 to 2030.

The market's progression is being driven by a fusion of factors which includes the ascendant preference of multiplex assays over singleplex varieties, advancements in companion diagnostics deploying multiplexing techniques, an amplified occurrence of chronic and infectious diseases, coupled with a heightened consciousness regarding the imperativeness of early disease detection.

Despite robust growth prospects, the market faces constraints such as the exorbitant costs associated with multiplex assay equipment. Moreover, complications such as the need for specialized skill sets and the potential for cross-reactivity present notable challenges.

Segment Insight

The protein multiplex assays domain is leading the types segment, exhibiting dominance in 2023, with bead-based assays contributing substantially within this category. The stronghold of this segment results from its critical role in diagnostics across varied domains such as allergies, cancer, and cardiovascular diseases. The consumables product segment takes precedence due to its recurrent utility and continuous advancements in diagnostic kits.

Technology Advancements and Applications

Flow cytometry is on the ascent as the technology projected to register the fastest growth, becoming an indispensable tool within clinical diagnosis and research realms. Simultaneously, the research & development application holds the largest share, propelled by intensifying applications in drug development and biomarker discovery.

End-user Insights and Geographical Outlook

Research & development end-users are anticipated to evolve at the most rapid rate, influenced by escalating investments by pharma and biotech firms into R&D, the proliferation of multiplex assays in novel drug discovery, and the pursuit of personalized medicine. North America emerges as the dominant regional player, owing to substantial R&D expenditure, a surge in chronic disease prevalence, and substantial healthcare investments.

This significant trend towards multiplex assays signals a paradigm shift in the diagnostic and R&D sectors, potentially transforming the landscape of pharmaceutical research and clinical diagnostics. The market's burgeoning expansion is supported by innovative product launches and strategic advancements by leading market players, as they align with the evolving demands of diagnostics and personalized medicine.

Prospective Market Trajectory

The future of the global multiplex assays market holds promise, with an encouraging growth pattern influenced by continued technological innovations, enhanced diagnostics methodologies, and a keen focus on streamlining R&D operations. This market is poised to impact significantly the realms of health management and disease diagnosis in the years to come.

Market Insights

Market Dynamics

• Advantages of Multiplex Assays over Singleplex Assays Leading to Their Increased Adoption
• Growing Use of Multiplexing in Companion Diagnostics Driving the Demand for Multiplex Assays
• High Costs of Multiplex Assay Equipment Hampering Adoption Among End Users
• Increasing Focus on Personalized Medicine Boosting the Utilization of Multiplex Assays
• Shortage of Skilled Professionals and the Risk of Cross-reactivity Limiting the Adoption of Multiplex Assays
• Factor Analysis

Technology Trends

• Technological Advancements in Multiplex PCR Technology
• Integration of Artificial Intelligence and Machine Learning into Multiplex Assay Systems
• Development of Smartphone-based Diagnostic Testing Platforms

Regulatory Analysis

• North America
• U.S.
• Canada
• Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Latin America
• Middle East & Africa

Pricing Analysis

Porter's Five Forces Analysis

Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories Inc. (U.S.)
• Seegene Inc. (South Korea)
• Qiagen N.V. (Netherlands)
• PerkinElmer Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies Inc. (U.S.)
• Abbott Laboratories (U.S.)
• Siemens Healthineers AG (Germany)
• Illumina Inc. (U.S.)
• Becton, Dickinson and Company (U.S.)
• Quanterix Corporation (U.S.)
• DiaSorin S.p.A. (Italy)
• Merck KGaA (Germany)

Competition Analysis

• Overview
• Key Growth Strategies
• Competitive Benchmarking
• Competitive Dashboard
• Industry Leaders
• Differentiators
• Vanguards
• Emerging Companies

Scope of the Report:

Multiplex Assays Market Assessment, by Type

• Protein Multiplex Assays
• Bead-based Assays
• Planar Assay
• Nucleic Acid Multiplex Assays
• Cell-based Multiplex Assays

Multiplex Assays Market Assessment, by Product

• Consumables
• Instruments
• Software & Services

Multiplex Assays Market Assessment, by Technology

• Flow Cytometry
• Multiplex Immunoassay
• Multiplex Real-Time PCR
• Sequencing
• Other Technologies

Note: Other technologies consist of microarray and immunohistochemistry

Multiplex Assays Market Assessment, by Application

• Research & Development
• Clinical Diagnosis
• Infectious Diseases
• Oncology
• Cardiovascular Diseases
• Autoimmune Diseases
• Other Diseases

Note: Other diseases include neurological diseases, thrombosis, and drug abuse testing.

Multiplex Assays Market Assessment, by End User

• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospitals
• Other End Users

Note: Other end users consist of academic institutes & research centers, forensic labs, agriculture companies, and food & beverage companies

Multiplex Assays Market Assessment, by Geography

North America

• U.S
• Canada

Europe

• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe (Roe)

Asia-Pacific (APAC)

• China
• Japan
• India
• Rest of Asia-Pacific (RoAPAC)

Latin America

• Brazil
• Mexico
• Rest of Latin America (RoLATAM)

Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/2rk9bb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240819361373/en/